Global  

Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks

DNA Saturday, 26 September 2020
On September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: India's vaccine will help all humanity in fighting COVID: PM Modi at UNGA

India's vaccine will help all humanity in fighting COVID: PM Modi at UNGA 02:20

While addressing the United Nations General Assembly (UNGA) Prime Minister Narendra Modi assured that India's vaccine production and delivery capacity will be used to help all humanity in fighting COVID-19 crisis. "From India's Neighbourhood First Policy to our Act East Policy, as well as idea of...

You Might Like


💡 One News Page Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

B-town celebs step out of homes in Mumbai amid COVID-19 [Video]

B-town celebs step out of homes in Mumbai amid COVID-19

Bollywood actor Ranbir Kapoor was snapped outside YRF studio in Mumbai's Andheri. Meanwhile, Saif Ali Khan was spotted in Bandra. He was seen in traditional attire. Yami Gautam was snapped post salon session in Juhu. She was seen wearing a mask to mitigate the spread of virus. Gauahar Khan and actor Zaid Darbar were spotted at Mumbai airport. Mrunal Thakur was also spotted in Bandra.

Credit: ANI    Duration: 01:36Published

Elderly who live with working-age people at higher Covid risk: Study

The study was conducted on 2,79,961 individuals aged 70 years or older. The mortality rate is over 20% in people above 70 years of age, says Dr Goel. Experts say..
IndiaTimes
China should allow scientists, doctors to investigate COVID, reiterates US [Video]

China should allow scientists, doctors to investigate COVID, reiterates US

The United States has reiterated its call urging China to allow scientists and doctors to investigate the origins of COVID-19, the pandemic which emerged from China. "There are global challenges in Asia where CCP broke their promises... COVID, that we are all dealing with, emanated from China. We continue to call on them to be transparent and open to allow scientists and doctors to investigate," said Morgan Ortagus, Spokesperson, US State Department.

Credit: ANI    Duration: 01:33Published
Small businesses team up with the American Cancer Society to put a dent in the $200M shortfall | The Rebound Tampa Bay [Video]

Small businesses team up with the American Cancer Society to put a dent in the $200M shortfall | The Rebound Tampa Bay

Nationally, the American Cancer Society said they are down $200 million because of COVID-19, and they are looking for businesses to team up with them and raise funds, no matter how big or small.

Credit: ABC Action News    Duration: 02:33Published

Germany imposes partial lockdown to control COVID's spread

German Chancellor Angela Merkel urged people to stay home in November so families and friends can meet again during the Christmas season.
CBS News

Adar Poonawalla Indian businessman

Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning [Video]

Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning

From the CEO of the world's largest vaccine manufacturer commenting on the possible timeline of the final vaccine reaching every person on the planet, to the World Health Organisation warning that the months of October and November 2020 could be 'tougher' - here are the top news updates on the Covid-19 pandemic. Adar Poonawalla, chief executive of Serum Institute of India reportedly said that it might take 4-5 years for the vaccine to reach everyone. He estimated that around 1,500 crore vaccine doses would be required to inoculate everyone if the final vaccine is a 2-dose drug. Meanwhile, the Government of India banned the export of onions after a 30% jump in export of the kitchen staple in the April-July 2020 period. Over a dozen Members of Parliament were found to be Covid positive on the day the central legislative body convened for its monsoon session. In Delhi, the deputy Chief Minister, Manish Sisodia, tested positive on the day that the Chief Minister of neighbouring Haryana, Manohar Lal Khattar, finally recovered from the disease. Watch the full video for the other top updates on the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 02:18Published

Drugs Controller General of India organization

ICMR issues advisory on CRISPR technology-based SARS CoV-2 test

The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General..
IndiaTimes

Russian Sputnik V Covid-19 vaccine to be tested on 100 Indian volunteers

The Russian Sputnik V vaccine against Covid-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug..
IndiaTimes
Covid update: N95 mask export allowed; India ranks 4th; festival guidelines [Video]

Covid update: N95 mask export allowed; India ranks 4th; festival guidelines

From the Union government lifting restrictions on the export of N-95/FFP2 face masks, to India ranking fourth in a survey of public perception regarding response to the pandemic - here are the top news updates on the Covid-19 outbreak. The central government released guidelines for gatherings as festival season approaches. The standard operating procedure involves mandatory use of masks, social distancing and CCTVs at event sites to monitor compliance. Event premises are also expected to have isolation rooms in case an infected person is found. The Drugs Controller General of India has asked Dr Reddy's Laboratories to file a revised protocol to conduct Phase 2 and 3 clinical trials of Russian vaccine Sputnik V in the country. Meanwhile, the International Monetary Fund said that the economic downturn caused by the pandemic was not as bad as originally feared, thanks to government spending measures. Watch the full video for the other updates regarding the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 03:14Published
COVID-19: DCGI approves CSIR's paper-based testing kit [Video]

COVID-19: DCGI approves CSIR's paper-based testing kit

Council of Scientific and Industrial Research on September 20 informed that Drugs Controller General of India has approved CSIR's paper-based testing kit called Feluda for COVID-19. CSIR, Director General S Mande said, "Our Delhi CSIR lab's been working on studying CRISPR-Cas immunity. They have experience of working in this particular area before COVID-19 and could repurpose the thing for COVID and developed a paper-based testing kit called Feluda and got formal approval from DCGA. Mande further explained the functioning of the paper based test. "It's different as RTPCR detects RNA and amplifies it using a polymerase chain reaction that is costly. This paper-based test also detects RNA but by a CRISPR guided system. The paper lights up if there is any virus RNA to show a sample is positive, in 45 minutes," he added.

Credit: ANI    Duration: 02:43Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines [Video]

Covid-19 cases dip, PM Modi calls for ‘speedy delivery’ of vaccines

As coronavirus infections continue to dip for the third consecutive week, Prime Minister Narendra Modi on Saturday called for a speedy delivery of Covid-19 vaccine once they are developed. Charing a high-level meet, the PM called for using the election infrastructure of the country for the speedy delivery of the vaccines. His remarks come on day the country’s drug controller allowed clinical trials of Russia’s Sputnik V vaccine candidate and the Serum Institute of India, which is to manufacture the Oxford vaccine candidate, said that India may get a Covid-19 vaccine by March next year. Top stories in this editorji evening playlist.

Credit: HT Digital Content    Duration: 05:47Published
Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon [Video]

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon

Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.

Credit: HT Digital Content    Duration: 01:19Published

AstraZeneca British-Swedish pharmaceutical company

Oxford COVID-19 vaccine trials produce robust immune response in elderly - FT

(Reuters) - Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca Plc, show it..
WorldNews
J&J, AstraZeneca resuming trials of vaccines [Video]

J&J, AstraZeneca resuming trials of vaccines

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:08Published

AstraZeneca, Johnson & Johnson to resume COVID-19 vaccine trials

On Friday, both AstraZeneca and Johnson & Johnson announced their coronavirus vaccine trials are set to resume in the U.S. after hitting pause when volunteers..
CBS News
Brazilian dies in COVID-19 vaccine trial [Video]

Brazilian dies in COVID-19 vaccine trial

A volunteer who was taking part in clinical trials of the AstraZeneca vaccine in Brazil has died. The Brazilian health authority has confirmed that the trial will continue. Flora Bradley-Watson reports.

Credit: Reuters Studio    Duration: 01:27Published

Covid 19 coronavirus AstraZeneca vaccine: Volunteer dies during human trials

A volunteer taking part in the trial for AstraZeneca's Covid-19 vaccine, which Australians could be given doses of, has died. A volunteer taking part in human..
New Zealand Herald

Related videos from verified sources

'You give vote, I'll give vaccine': Sena, Owaisi slam BJP's Bihar poll promise [Video]

'You give vote, I'll give vaccine': Sena, Owaisi slam BJP's Bihar poll promise

The Bharatiya Janata Party is facing criticism from its political opponents over a promise made in its election manifesto for Bihar. Shiv Sena's Sanjay Raut said BJP's promise of free Covid vaccines..

Credit: HT Digital Content     Duration: 04:59Published
Bihar Polls 2020: BJP announces free vaccine for all in Bihar, faces heat | Oneindia News [Video]

Bihar Polls 2020: BJP announces free vaccine for all in Bihar, faces heat | Oneindia News

The BJP's free coronavirus vaccination for all promise in Bihar ahead of next week's election has become hugely controversial with the ruling party fending off allegations of an attempt to use the..

Credit: Oneindia     Duration: 02:24Published
Future will be shaped by those who invest in science, innovation: PM Modi [Video]

Future will be shaped by those who invest in science, innovation: PM Modi

Prime Minister Narendra Modi attended inaugural function of Grand Challenges Annual Meeting 2020 via video-conferencing on October 18. Microsoft founder Bill Gates also interacted with PM Modi during..

Credit: ANI     Duration: 03:22Published

Related news from verified sources

DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine

The central drug regulator has issued a show-cause notice to the Serum Institute of India (SII) for not informing it about pharma giant AstraZeneca pausing the...
Mid-Day Also reported by •InvezzDNA

Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK

Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its Covid-19...
Mid-Day Also reported by •InvezzSydney Morning HeraldIndiaTimesDNAUSATODAY.comNews24WorldNewsThe AgeBusiness InsiderRTTNews

Coronavirus updates: AstraZeneca halts vaccine trials; Trump accuses NC of politicizing pandemic; Honolulu extends stay-at-home order

AstraZeneca puts vaccine trials on hold. Honolulu extends stay-at-home order. Trump accuses North Carolina of politicizing the pandemic. Latest COVID-19 news.
USATODAY.com Also reported by •News24WorldNews

Tweets about this